Ispaghula husk

CLINICAL USE

Bulk-forming laxative

DOSE IN NORMAL RENAL FUNCTION

Fibrelief: 1–6 sachets daily in water in 1–3 divided dosesFybogel: One sachet (3.5 g) in water twice dailyIsogel: 2 teaspoonfuls in water 1–2 times daily (constipation), 3 times daily (diarrhoea)Regulan: 1 sachet in water 1–3 times daily

PHARMACOKINETICS

  • Molecular weight                           :–
  • %Protein binding                           :0
  • %Excreted unchanged in urine     : 0
  • Volume of distribution (L/kg)       :Not absorbed
  • half-life – normal/ESRD (hrs)      :Not absorbed

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. Dose as in normal renal function
  • HD                     :Not dialysed. Dose as in normal renal function
  • HDF/high flux   :Not dialysed. Dose as in normal renal function
  • CAV/VVHD      :Not dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs

  • None known

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    Fybogel and regulan should be stirred into 150 mL water and taken as quickly as possible, preferably after mealsAdditional fluid intake should be maintained

    OTHER INFORMATION

    Fybogel is low in sodium and potassium, containing approximately 0.4 mmol sodium and 0.7 mmol potassium per sachet. It is sugar and gluten free and contains aspartame (contributes to the phenylalanine intake and may affect control of phenylketonuria)Orange and lemon/lime flavours of regulan contain: 3.4 g ispaghula husk BP, 0.23 mmol sodium, <1 mmol potassium per sachet and are gluten and sugar free. They also contain aspartameFibrelief contains aspartame Fluid restrictions in dialysis patients can render these treatments inappropriate

  • Related News